167 research outputs found
Biomedical applications of belief networks
Biomedicine is an area in which computers have long been expected to play a significant
role. Although many of the early claims have proved unrealistic, computers are gradually
becoming accepted in the biomedical, clinical and research environment. Within these
application areas, expert systems appear to have met with the most resistance, especially
when applied to image interpretation.In order to improve the acceptance of computerised decision support systems it is
necessary to provide the information needed to make rational judgements concerning
the inferences the system has made. This entails an explanation of what inferences
were made, how the inferences were made and how the results of the inference are to
be interpreted. Furthermore there must be a consistent approach to the combining of
information from low level computational processes through to high level expert analyses.nformation from low level computational processes through to high level expert analyses.
Until recently ad hoc formalisms were seen as the only tractable approach to reasoning
under uncertainty. A review of some of these formalisms suggests that they are less
than ideal for the purposes of decision making. Belief networks provide a tractable way
of utilising probability theory as an inference formalism by combining the theoretical
consistency of probability for inference and decision making, with the ability to use the
knowledge of domain experts.nowledge of domain experts.
The potential of belief networks in biomedical applications has already been recogÂŹ
nised and there has been substantial research into the use of belief networks for medical
diagnosis and methods for handling large, interconnected networks. In this thesis the use
of belief networks is extended to include detailed image model matching to show how,
in principle, feature measurement can be undertaken in a fully probabilistic way. The
belief networks employed are usually cyclic and have strong influences between adjacent
nodes, so new techniques for probabilistic updating based on a model of the matching
process have been developed.An object-orientated inference shell called FLAPNet has been implemented and used
to apply the belief network formalism to two application domains. The first application is
model-based matching in fetal ultrasound images. The imaging modality and biological
variation in the subject make model matching a highly uncertain process. A dynamic,
deformable model, similar to active contour models, is used. A belief network combines
constraints derived from local evidence in the image, with global constraints derived from
trained models, to control the iterative refinement of an initial model cue.In the second application a belief network is used for the incremental aggregation of
evidence occurring during the classification of objects on a cervical smear slide as part of
an automated pre-screening system. A belief network provides both an explicit domain
model and a mechanism for the incremental aggregation of evidence, two attributes
important in pre-screening systems.Overall it is argued that belief networks combine the necessary quantitative features
required of a decision support system with desirable qualitative features that will lead
to improved acceptability of expert systems in the biomedical domain
Neonatal rotavirus vaccine (RV3-BB) immunogenicity and safety in a neonatal and infant administration schedule in Malawi: a randomised, double-blind, four-arm parallel group dose-ranging study.
BackgroundRotavirus vaccines reduce rotavirus-related deaths and hospitalisations but are less effective in high child mortality countries. The human RV3-BB neonatal G3P[6] rotavirus vaccine administered in a neonatal schedule was efficacious in reducing severe rotavirus gastroenteritis in Indonesia but had not yet been evaluated in African infants.MethodsWe did a phase 2, randomised, double-blind, parallel group dose-ranging study of three doses of oral RV3-BB rotavirus vaccine in infants in three primary health centres in Blantyre, Malawi. Healthy infants less than 6 days of age with a birthweight 2·5 to 4·0 kg were randomly assigned (1:1:1:1) into one of four treatment groups: neonatal vaccine group, which included high-titre (1·0âĂâ107 focus-forming unit [FFU] per mL), mid-titre (3·0âĂâ106 FFU per mL), or low-titre (1·0âĂâ106 FFU per mL); and infant vaccine group, which included high-titre (1·0âĂâ107 FFU per mL) using a computer generated code (block size of four), stratified by birth (singleton vs multiple). Neonates received their three doses at 0-5 days to 10 weeks and infants at 6-14 weeks. Investigators, participant families, and laboratory staff were masked to group allocation. Anti-rotavirus IgA seroconversion and vaccine take (IgA seroconversion and stool shedding) were evaluated. Safety was assessed in all participants who received at least one dose of vaccine or placebo. The primary outcome was the cumulative IgA seroconversion 4 weeks after three doses of RV3-BB in the neonatal schedule in the high-titre, mid-titre, and low-titre groups in the per protocol population, with its 95% CI. With the high-titre group as the active control group, we did a non-inferiority analysis of the proportion of participants with IgA seroconversion in the mid-titre and low-titre groups, using a non-inferiority margin of less than 20%. This trial is registered at ClinicalTrials.gov (NCT03483116).FindingsBetween Sept 17, 2018, and Jan 27, 2020, 711 participants recruited were randomly assigned into four treatment groups (neonatal schedule high titre n=178, mid titre n=179, low titre n=175, or infant schedule high titre n=179). In the neonatal schedule, cumulative IgA seroconversion 4 weeks after three doses of RV3-BB was observed in 79 (57%) of 139 participants in the high-titre group, 80 (57%) of 141 participants in the mid-titre group, and 57 (41%) of 138 participants in the low-titre group and at 18 weeks in 100 (72%) of 139 participants in the high-titre group, 96 (67%) of 143 participants in the mid-titre group, and 86 (62%) of 138 of participants in the low-titre. No difference in cumulative IgA seroconversion 4 weeks after three doses of RV3-BB was observed between high-titre and mid-titre groups in the neonatal schedule (difference in response rate 0·001 [95%CI -0·115 to 0·117]), fulfilling the criteria for non-inferiority. In the infant schedule group 82 (59%) of 139 participants had a cumulative IgA seroconversion 4 weeks after three doses of RV3-BB at 18 weeks. Cumulative vaccine take was detected in 483 (85%) of 565 participants at 18 weeks. Three doses of RV3-BB were well tolerated with no difference in adverse events among treatment groups: 67 (39%) of 170 participants had at least one adverse event in the high titre group, 68 (40%) of 172 participants had at least one adverse event in the mid titre group, and 69 (41%) of 169 participants had at least one adverse event in the low titre group.InterpretationRV3-BB was well tolerated and immunogenic when co-administered with Expanded Programme on Immunisation vaccines in a neonatal or infant schedule. A lower titre (mid-titre) vaccine generated similar IgA seroconversion to the high-titre vaccine presenting an opportunity to enhance manufacturing capacity and reduce costs. Neonatal administration of the RV3-BB vaccine has the potential to improve protection against rotavirus disease in children in a high-child mortality country in Africa.FundingBill & Melinda Gates Foundation, Australian Tropical Medicine Commercialisation Grant
Rotavirus Genotypes in Hospitalized Children With Acute Gastroenteritis Before and After Rotavirus Vaccine Introduction in Blantyre, Malawi, 1997-2019
BACKGROUND: Rotavirus vaccine (Rotarix [RV1]) has reduced diarrhea-associated hospitalizations and deaths in Malawi. We examined the trends in circulating rotavirus genotypes in Malawi over a 22-year period to assess the impact of RV1 introduction on strain distribution. METHODS: Data on rotavirus-positive stool specimens among children aged <5 years hospitalized with diarrhea in Blantyre, Malawi before (July 1997-October 2012, n = 1765) and after (November 2012-October 2019, n = 934) RV1 introduction were analyzed. Rotavirus G and P genotypes were assigned using reverse-transcription polymerase chain reaction. RESULTS: A rich rotavirus strain diversity circulated throughout the 22-year period; Shannon (H') and Simpson diversity (D') indices did not differ between the pre- and postvaccine periods (H' P < .149; D' P < .287). Overall, G1 (n = 268/924 [28.7%]), G2 (n = 308/924 [33.0%]), G3 (n = 72/924 [7.7%]), and G12 (n = 109/924 [11.8%]) were the most prevalent genotypes identified following RV1 introduction. The prevalence of G1P[8] and G2P[4] genotypes declined each successive year following RV1 introduction, and were not detected after 2018. Genotype G3 reemerged and became the predominant genotype from 2017 onward. No evidence of genotype selection was observed 7 years post-RV1 introduction. CONCLUSIONS: Rotavirus strain diversity and genotype variation in Malawi are likely driven by natural mechanisms rather than vaccine pressure
Les droits disciplinaires des fonctions publiques : « unification », « harmonisation » ou « distanciation ». A propos de la loi du 26 avril 2016 relative à la déontologie et aux droits et obligations des fonctionnaires
The production of tt⟠, W+bb⟠and W+cc⟠is studied in the forward region of protonâproton collisions collected at a centre-of-mass energy of 8 TeV by the LHCb experiment, corresponding to an integrated luminosity of 1.98±0.02 fbâ1 . The W bosons are reconstructed in the decays WââÎœ , where â denotes muon or electron, while the b and c quarks are reconstructed as jets. All measured cross-sections are in agreement with next-to-leading-order Standard Model predictions.The production of , and is studied in the forward region of proton-proton collisions collected at a centre-of-mass energy of 8 TeV by the LHCb experiment, corresponding to an integrated luminosity of 1.98 0.02 \mbox{fb}^{-1}. The bosons are reconstructed in the decays , where denotes muon or electron, while the and quarks are reconstructed as jets. All measured cross-sections are in agreement with next-to-leading-order Standard Model predictions
Observation of the B0 â Ï0Ï0 decay from an amplitude analysis of B0 â (Ï+Ïâ)(Ï+Ïâ) decays
Protonâproton collision data recorded in 2011 and 2012 by the LHCb experiment, corresponding to an integrated luminosity of 3.0 fbâ1 , are analysed to search for the charmless B0âÏ0Ï0 decay. More than 600 B0â(Ï+Ïâ)(Ï+Ïâ) signal decays are selected and used to perform an amplitude analysis, under the assumption of no CP violation in the decay, from which the B0âÏ0Ï0 decay is observed for the first time with 7.1 standard deviations significance. The fraction of B0âÏ0Ï0 decays yielding a longitudinally polarised final state is measured to be fL=0.745â0.058+0.048(stat)±0.034(syst) . The B0âÏ0Ï0 branching fraction, using the B0âÏKâ(892)0 decay as reference, is also reported as B(B0âÏ0Ï0)=(0.94±0.17(stat)±0.09(syst)±0.06(BF))Ă10â6
Angular analysis of the B-0 -> K*(0) e(+) e(-) decay in the low-q(2) region
An angular analysis of the decay is performed using a data sample, corresponding to an integrated luminosity of 3.0 {\mbox{fb}^{-1}}, collected by the LHCb experiment in collisions at centre-of-mass energies of 7 and 8 TeV during 2011 and 2012. For the first time several observables are measured in the dielectron mass squared () interval between 0.002 and 1.120. The angular observables and which are related to the polarisation and to the lepton forward-backward asymmetry, are measured to be and , where the first uncertainty is statistical and the second systematic. The angular observables and which are sensitive to the photon polarisation in this range, are found to be and . The results are consistent with Standard Model predictions.An angular analysis of the B â K^{*}^{0} e e decay is performed using a data sample, corresponding to an integrated luminosity of 3.0 fb, collected by the LHCb experiment in pp collisions at centre-of-mass energies of 7 and 8 TeV during 2011 and 2012. For the first time several observables are measured in the dielectron mass squared (q) interval between 0.002 and 1.120 GeV /c. The angular observables F and A which are related to the K^{*}^{0} polarisation and to the lepton forward-backward asymmetry, are measured to be F = 0.16 ± 0.06 ± 0.03 and A â=â0.10â±â0.18â±â0.05, where the first uncertainty is statistical and the second systematic. The angular observables A and A which are sensitive to the photon polarisation in this q range, are found to be A â=âââ0.23â±â0.23â±â0.05 and A â=â0.14â±â0.22â±â0.05. The results are consistent with Standard Model predictions.An angular analysis of the decay is performed using a data sample, corresponding to an integrated luminosity of 3.0 {\mbox{fb}^{-1}}, collected by the LHCb experiment in collisions at centre-of-mass energies of 7 and 8 TeV during 2011 and 2012. For the first time several observables are measured in the dielectron mass squared () interval between 0.002 and 1.120. The angular observables and which are related to the polarisation and to the lepton forward-backward asymmetry, are measured to be and , where the first uncertainty is statistical and the second systematic. The angular observables and which are sensitive to the photon polarisation in this range, are found to be and . The results are consistent with Standard Model predictions
Measurement of the Z plus b-jet cross-section in pp collisions at root s=7 TeV in the forward region
The associated production of a Z boson or an off-shell photon with a bottom quark in the forward region is studied using proton-proton collisions at a centre-of-mass energy of . The Z bosons are reconstructed in the final state from muons with a transverse momentum larger than , while two transverse momentum thresholds are considered for jets ( and ). Both muons and jets are reconstructed in the pseudorapidity range , and \sigma(\text{\text{Z}/\gamma^*(\mu^{+}\mu^{-})+b-jet}) = 167 \pm 47 (\text{stat}) \pm 29 (\text{syst}) \pm 6 (\text{lumi}) {\,{fb}} for {p_{\rm T}}(jet)
Study of the rare B-s(0) and B-0 decays into the pi(+) pi(-) mu(+) mu(-) final state
A search for the rare decays and is performed in a data set corresponding to an integrated luminosity of 3.0 fb collected by the LHCb detector in proton-proton collisions at centre-of-mass energies of 7 and 8 TeV. Decay candidates with pion pairs that have invariant mass in the range 0.5-1.3 GeV/ and with muon pairs that do not originate from a resonance are considered. The first observation of the decay and the first evidence of the decay are obtained and the branching fractions are measured to be and , where the third uncertainty is due to the branching fraction of the decay , used as a normalisation.A search for the rare decays Bs0âÏ+ÏâÎŒ+ÎŒâ and B0âÏ+ÏâÎŒ+ÎŒâ is performed in a data set corresponding to an integrated luminosity of 3.0 fbâ1 collected by the LHCb detector in protonâproton collisions at centre-of-mass energies of 7 and 8 TeV . Decay candidates with pion pairs that have invariant mass in the range 0.5â1.3 GeV/c2 and with muon pairs that do not originate from a resonance are considered. The first observation of the decay Bs0âÏ+ÏâÎŒ+ÎŒâ and the first evidence of the decay B0âÏ+ÏâÎŒ+ÎŒâ are obtained and the branching fractions, restricted to the dipion-mass range considered, are measured to be B(Bs0âÏ+ÏâÎŒ+ÎŒâ)=(8.6±1.5 (stat)±0.7 (syst)±0.7(norm))Ă10â8 and B(B0âÏ+ÏâÎŒ+ÎŒâ)=(2.11±0.51(stat)±0.15(syst)±0.16(norm))Ă10â8 , where the third uncertainty is due to the branching fraction of the decay B0âJ/Ï(âÎŒ+ÎŒâ)Kâ(892)0(âK+Ïâ) , used as a normalisation.A search for the rare decays Bs0âÏ+ÏâÎŒ+ÎŒâ and B0âÏ+ÏâÎŒ+ÎŒâ is performed in a data set corresponding to an integrated luminosity of 3.0 fbâ1 collected by the LHCb detector in protonâproton collisions at centre-of-mass energies of 7 and 8 TeV . Decay candidates with pion pairs that have invariant mass in the range 0.5â1.3 GeV/c2 and with muon pairs that do not originate from a resonance are considered. The first observation of the decay Bs0âÏ+ÏâÎŒ+ÎŒâ and the first evidence of the decay B0âÏ+ÏâÎŒ+ÎŒâ are obtained and the branching fractions, restricted to the dipion-mass range considered, are measured to be B(Bs0âÏ+ÏâÎŒ+ÎŒâ)=(8.6±1.5 (stat)±0.7 (syst)±0.7(norm))Ă10â8 and B(B0âÏ+ÏâÎŒ+ÎŒâ)=(2.11±0.51(stat)±0.15(syst)±0.16(norm))Ă10â8 , where the third uncertainty is due to the branching fraction of the decay B0âJ/Ï(âÎŒ+ÎŒâ)Kâ(892)0(âK+Ïâ) , used as a normalisation.A search for the rare decays and is performed in a data set corresponding to an integrated luminosity of 3.0 fb collected by the LHCb detector in proton-proton collisions at centre-of-mass energies of 7 and 8 TeV. Decay candidates with pion pairs that have invariant mass in the range 0.5-1.3 GeV/ and with muon pairs that do not originate from a resonance are considered. The first observation of the decay and the first evidence of the decay are obtained and the branching fractions, restricted to the dipion-mass range considered, are measured to be and , where the third uncertainty is due to the branching fraction of the decay , used as a normalisation
Search for the lepton flavour violating decay tau(-) -> mu(-)mu(+)mu(-)
A search for the lepton flavour violating decay is performed with the LHCb experiment. The data sample corresponds to an integrated luminosity of 1.0 fb of proton-proton collisions at a centre-of-mass energy of 7 TeV and 2.0 fb at 8 TeV. No evidence is found for a signal, and a limit is set at 90% confidence level on the branching fraction, .A search for the lepton flavour violating decay Ï â ÎŒ ÎŒ ÎŒ is performed with the LHCb experiment. The data sample corresponds to an integrated luminosity of 1.0 fb of proton-proton collisions at a centre-of-mass energy of 7 TeV and 2.0 fb at 8 TeV. No evidence is found for a signal, and a limit is set at 90% confidence level on the branching fraction, .A search for the lepton flavour violating decay is performed with the LHCb experiment. The data sample corresponds to an integrated luminosity of of proton-proton collisions at a centre-of-mass energy of and at . No evidence is found for a signal, and a limit is set at confidence level on the branching fraction,
- âŠ